Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.

Saved in:
Bibliographic Details
Title: Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
Authors: Ross TT; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Crowley C; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Kelly KL; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Rinaldi A; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Beebe DA; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Lech MP; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Martinez RV; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Carvajal-Gonzalez S; Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Boucher M; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Hirenallur-Shanthappa D; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Morin J; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Opsahl AC; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Vargas SR; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Bence KK; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Pfefferkorn JA; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Esler WP; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts. Electronic address: William.Esler@Pfizer.com.
Source: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (4), pp. 829-851. Date of Electronic Publication: 2020 Jun 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Gastroenterological Association Country of Publication: United States NLM ID: 101648302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-345X (Electronic) Linking ISSN: 2352345X NLM ISO Abbreviation: Cell Mol Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32526482
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ross+TT%22">Ross TT</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Crowley+C%22">Crowley C</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kelly+KL%22">Kelly KL</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rinaldi+A%22">Rinaldi A</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Beebe+DA%22">Beebe DA</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lech+MP%22">Lech MP</searchLink>; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Martinez+RV%22">Martinez RV</searchLink>; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Carvajal-Gonzalez+S%22">Carvajal-Gonzalez S</searchLink>; Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Boucher+M%22">Boucher M</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hirenallur-Shanthappa+D%22">Hirenallur-Shanthappa D</searchLink>; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Morin+J%22">Morin J</searchLink>; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Opsahl+AC%22">Opsahl AC</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Vargas+SR%22">Vargas SR</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bence+KK%22">Bence KK</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pfefferkorn+JA%22">Pfefferkorn JA</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Esler+WP%22">Esler WP</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts. Electronic address: William.Esler@Pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648302%22">Cellular and molecular gastroenterology and hepatology</searchLink> [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (4), pp. 829-851. <i>Date of Electronic Publication: </i>2020 Jun 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Gastroenterological+Association%22">American Gastroenterological Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101648302 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-345X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222352345X%22">2352345X </searchLink><i>NLM ISO Abbreviation: </i>Cell Mol Gastroenterol Hepatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32526482
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcmgh.2020.06.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 829
    Titles:
      – TitleFull: Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ross TT
      – PersonEntity:
          Name:
            NameFull: Crowley C
      – PersonEntity:
          Name:
            NameFull: Kelly KL
      – PersonEntity:
          Name:
            NameFull: Rinaldi A
      – PersonEntity:
          Name:
            NameFull: Beebe DA
      – PersonEntity:
          Name:
            NameFull: Lech MP
      – PersonEntity:
          Name:
            NameFull: Martinez RV
      – PersonEntity:
          Name:
            NameFull: Carvajal-Gonzalez S
      – PersonEntity:
          Name:
            NameFull: Boucher M
      – PersonEntity:
          Name:
            NameFull: Hirenallur-Shanthappa D
      – PersonEntity:
          Name:
            NameFull: Morin J
      – PersonEntity:
          Name:
            NameFull: Opsahl AC
      – PersonEntity:
          Name:
            NameFull: Vargas SR
      – PersonEntity:
          Name:
            NameFull: Bence KK
      – PersonEntity:
          Name:
            NameFull: Pfefferkorn JA
      – PersonEntity:
          Name:
            NameFull: Esler WP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2352-345X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cellular and molecular gastroenterology and hepatology
              Type: main
ResultId 1